{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:15:11Z","timestamp":1782962111607,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Katholisches Klinikum Bochum gGmbh"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Numerous studies reported a higher prevalence of polyneuropathy (PNP) in patients with Parkinson\u2019s disease (PD) compared to the general population. Importantly, PNP symptoms can aggravate both motor and sensory disturbances in PD patients and negatively impact the disease course. Recent analyses indicate distinct PNP patterns in PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main text<\/jats:title>\n                <jats:p>This review aims to provide an overview of the current insights into etiological factors, diagnostic methods, and management strategies of large fiber neuropathy in PD. Despite the higher prevalence, the causes of PNP in PD are still not fully understood. A genetic predisposition can underlie PNP onset in PD. Main research attention is focused on long-term levodopa exposure which is suggested to increase PNP risk by depletion of methylation cofactors such as vitamin B12 and accumulation of homocysteine that altogether can alter peripheral nerve homeostasis. Beyond a potential \u201ciatrogenic\u201d cause, alpha-synuclein deposition has been detected in sural nerve fibers that could contribute to peripheral neuronal degeneration as part of the systemic manifestation of PD. Whereas mild axonal sensory PNP predominates in PD, a considerable proportion of patients also show motor and upper limb nerve involvement. Intriguingly, a correlation between PNP severity and PD severity has been demonstrated. Therefore, PNP screening involving clinical and instrument-based assessments should be implemented in the clinical routine for early detection and monitoring. Given the etiological uncertainty, therapeutic or preventive options remain limited. Vitamin supplementation and use of catechol-O-methyltransferase-inhibitors can be taken into consideration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PNP is increasingly recognized as a complicating comorbidity of PD patients. Long-term, large-scale prospective studies are required to elucidate the causative factors for the development and progression of PD-associated PNP to optimize treatment approaches. The overall systemic role of \u201cidiopathic\u201d PNP in PD and a putative association with the progression of neurodegeneration should also be investigated further.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42466-024-00354-z","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:43:17Z","timestamp":1730104997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Large-fiber neuropathy in Parkinson\u2019s disease: a narrative review"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5051-0652","authenticated-orcid":false,"given":"Eun Hae","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Steininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Pitarokoili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"T\u00f6nges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"Suppl 1","key":"354_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S., & Bloem, B. R. (2018). The emerging evidence of the parkinson pandemic. Journal of Parkinson\u2019s Disease, 8(Suppl 1), S3-8.","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"4","key":"354_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz, J. D., Seeher, K. M., Schiess, N., Nichols, E., Cao, B., Servili, C., Cavallera, V., Cousin, E., Hagins, H., Moberg, M. E., & Mehlman, M. L. (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the global burden of disease study 2021. The Lancet Neurology, 23(4), 344\u2013381.","journal-title":"The Lancet Neurology"},{"issue":"6","key":"354_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., Sabbagh, M. N., & Walker, D. G. (2010). Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders. Acta neuropathologica, 119(6), 689\u2013702.","journal-title":"Acta neuropathologica"},{"issue":"2","key":"354_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0972-2327.41875","volume":"11","author":"UK Misra","year":"2008","unstructured":"Misra, U. K., Kalita, J., & Nair, P. P. (2008). Diagnostic approach to peripheral neuropathy. Annals of Indian Academy of Neurology, 11(2), 89\u201397.","journal-title":"Annals of Indian Academy of Neurology"},{"issue":"4","key":"354_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1445-5994.1991.tb01337.x","volume":"21","author":"MT Bulling","year":"1991","unstructured":"Bulling, M. T., Wing, L. M., & Burns, R. J. (1991). Controlled release levodopa\/carbidopa (Sinemet CR4) in Parkinson\u2019s disease\u2013an open evaluation of efficacy and safety. Australian and New Zealand Journal of Medicine, 21(4), 397\u2013400.","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"10","key":"354_CR6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.25585","volume":"28","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo, R., Cossu, G., Di Bandettini Poggio, M., Santoro, L., Barone, P., Zibetti, M., Frosini, D., Nicoletti, V., Manganelli, F., Iodice, R., Picillo, M., Merola, A., Lopiano, L., Paribello, A., Manca, D., Melis, M., Marchese, R., Borelli, P., Mereu, A., \u2026 Bonuccelli, U. (2013). Neuropathy and levodopa in Parkinson\u2019s disease: Evidence from a multicenter study. Movement Disorders: Official Journal of the Movement Disorder Society, 28(10), 1391\u20131397.","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"10","key":"354_CR7","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1002\/acn3.51182","volume":"7","author":"E K\u00fchn","year":"2020","unstructured":"K\u00fchn, E., Averdunk, P., Huckemann, S., M\u00fcller, K., Biesalski, A.-S., Zum Hof Berge, F., Motte, J., Fisse, A. L., Schneider-Gold, C., Gold, R., Pitarokoili, K., & T\u00f6nges, L. (2020). Correlates of polyneuropathy in Parkinson\u2019s disease. Annals of Clinical and Translational Neurology, 7(10), 1898\u20131907.","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jns.2017.05.023","volume":"378","author":"P Zis","year":"2017","unstructured":"Zis, P., Gr\u00fcnewald, R. A., Chaudhuri, R. K., & Hadjivassiliou, M. (2017). Peripheral neuropathy in idiopathic Parkinson\u2019s disease: A systematic review. Journal of the Neurological Sciences, 378, 204\u2013209.","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"354_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.parkreldis.2014.10.010","volume":"20","author":"C Comi","year":"2014","unstructured":"Comi, C., Magistrelli, L., Oggioni, G. D., Carecchio, M., Fleetwood, T., Cantello, R., Mancini, F., & Antonini, A. (2014). Peripheral nervous system involvement in Parkinson\u2019s disease: Evidence and controversies. Parkinsonism & Related Disorders, 20(12), 1329\u20131334.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"354_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mdc3.12217","volume":"2","author":"V Mylius","year":"2015","unstructured":"Mylius, V., Ciampi, D., de Andrade, R. G., Cury, M. T., Ehrt, U., Eggert, K. M., Beer, S., Kesselring, J., Stamelou, M., Oertel, W. H., M\u00f6ller, J. C., & Lefaucheur, J.-P. (2015). Pain in Parkinson\u2019s disease: Current concepts and a new diagnostic algorithm. Movement Disorders Clinical Practice, 2(4), 357\u2013364.","journal-title":"Movement Disorders Clinical Practice"},{"key":"354_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.parkreldis.2018.04.006","volume":"54","author":"ML Beaulieu","year":"2018","unstructured":"Beaulieu, M. L., M\u00fcller, M. L. T. M., & Bohnen, N. I. (2018). Peripheral neuropathy is associated with more frequent falls in Parkinson\u2019s disease. Parkinsonism & Related Disorders, 54, 46\u201350.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"354_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/brain\/awac026","volume":"146","author":"MF Corr\u00e0","year":"2023","unstructured":"Corr\u00e0, M. F., Vila-Ch\u00e3, N., Sardoeira, A., Hansen, C., Sousa, A. P., Reis, I., Sambayeta, F., Dam\u00e1sio, J., Calejo, M., Schicketmueller, A., Laranjinha, I., Salgado, P., Taipa, R., Magalh\u00e3es, R., Correia, M., Maetzler, W., & Maia, L. F. (2023). Peripheral neuropathy in Parkinson\u2019s disease: Prevalence and functional impact on gait and balance. Brain\u202f: A Journal of Neurology, 146(1), 225\u2013236.","journal-title":"Brain : A Journal of Neurology"},{"issue":"1","key":"354_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler","year":"2014","unstructured":"Doppler, K., Ebert, S., \u00dc\u00e7eyler, N., Trenkwalder, C., Ebentheuer, J., Volkmann, J., & Sommer, C. (2014). Cutaneous neuropathy in Parkinson\u2019s disease: A window into brain pathology. Acta neuropathologica, 128(1), 99\u2013109.","journal-title":"Acta neuropathologica"},{"issue":"8","key":"354_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/WNL.0000000000004274","volume":"89","author":"M Nolano","year":"2017","unstructured":"Nolano, M., Provitera, V., Manganelli, F., Iodice, R., Stancanelli, A., Caporaso, G., Saltalamacchia, A., Califano, F., Lanzillo, B., Picillo, M., Barone, P., & Santoro, L. (2017). Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients. Neurology, 89(8), 776\u2013784.","journal-title":"Neurology"},{"key":"354_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.parkreldis.2016.04.033","volume":"28","author":"PJ Podgorny","year":"2016","unstructured":"Podgorny, P. J., Suchowersky, O., Romanchuk, K. G., & Feasby, T. E. (2016). Evidence for small fiber neuropathy in early Parkinson\u2019s disease. Parkinsonism & Related Disorders, 28, 94\u201399.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"354_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41531-021-00262-y","volume":"7","author":"E Vacchi","year":"2021","unstructured":"Vacchi, E., Senese, C., Chiaro, G., Disanto, G., Pinton, S., Morandi, S., Bertaina, I., Bianco, G., Staedler, C., Galati, S., Gobbi, C., Kaelin-Lang, A., & Melli, G. (2021). Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson\u2019s disease. NPJ Parkinson\u2019s Disease, 7(1), 119.","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"11","key":"354_CR17","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/mds.23342","volume":"25","author":"PP Urban","year":"2010","unstructured":"Urban, P. P., Wellach, I., Faiss, S., Layer, P., Rosenkranz, T., Knop, K., & Weis, J. (2010). Subacute axonal neuropathy in Parkinson\u2019s disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Movement disorders: Official journal of the Movement Disorder Society, 25(11), 1748\u20131752.","journal-title":"Movement disorders: Official journal of the Movement Disorder Society"},{"issue":"9","key":"354_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.parkreldis.2013.05.002","volume":"19","author":"T Kimber","year":"2013","unstructured":"Kimber, T., Blumbergs, P., & Thompson, P. (2013). Severe ataxic polyneuropathy associated with chronic levodopa use in Parkinson\u2019s disease. Parkinsonism & Related Disorders, 19(9), 847\u2013849.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"354_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/jns5.12056","volume":"19","author":"A Vital","year":"2014","unstructured":"Vital, A., Meissner, W. G., Canron, M.-H., Martin-Negrier, M.-L., Bezard, E., Tison, F., & Vital, C. (2014). Intra-axonal protein aggregation in the peripheral nervous system. Journal of the Peripheral Nervous System\u202f: JPNS, 19(1), 44\u201349.","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"key":"354_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2018.10.003","volume":"60","author":"H Zhang","year":"2019","unstructured":"Zhang, H., Zhu, L., Sun, L., Zhi, Y., Ding, J., Yuan, Y.-S., Shen, F.-F., Li, X., Ji, P., Wang, Z., Niu, Q., & Zhang, K.-Z. (2019). Phosphorylated \u03b1-synuclein deposits in sural nerve deriving from Schwann cells: A biomarker for Parkinson\u2019s disease. Parkinsonism & Related Disorders, 60, 57\u201363.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"354_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cns.13282","volume":"26","author":"H Zhang","year":"2019","unstructured":"Zhang, H., Wu, J., Shen, F.-F., Yuan, Y.-S., Li, X., Ji, P., Zhu, L., Sun, L., Ding, J., Niu, Q., & Zhang, K.-Z. (2019). Activated Schwann cells and increased inflammatory cytokines IL-1\u03b2, IL-6, and TNF-\u03b1 in patients\u2019 sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson\u2019s disease. CNS Neuroscience & Therapeutics, 26(5), 518\u2013526.","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"354_CR22","doi-asserted-by":"publisher","first-page":"135964","DOI":"10.1016\/j.neulet.2021.135964","volume":"756","author":"Z Rong","year":"2021","unstructured":"Rong, Z., Shen, F., Wang, Y., Sun, L., Wu, J., Zhang, H., Yuan, Y., Jiang, W., Li, X., Ji, P., & Zhang, K. (2021). Phosphorylated \u03b1-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson\u2019s disease from multiple system atrophy and progressive supranuclear paralysis. Neuroscience Letters, 756, 135964.","journal-title":"Neuroscience Letters"},{"issue":"11","key":"354_CR23","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1007\/s00415-013-7079-8","volume":"260","author":"YA Rajabally","year":"2013","unstructured":"Rajabally, Y. A., & Martey, J. (2013). Levodopa, vitamins, ageing and the neuropathy of Parkinson\u2019s disease. Journal of Neurology, 260(11), 2844\u20132848.","journal-title":"Journal of Neurology"},{"key":"354_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","volume":"31","author":"R Hanewinckel","year":"2015","unstructured":"Hanewinckel, R., van Oijen, M., Ikram, M. A., & van Doorn, P. A. (2015). The epidemiology and risk factors of chronic polyneuropathy. European Journal of Epidemiology, 31, 5\u201320.","journal-title":"European Journal of Epidemiology"},{"issue":"13","key":"354_CR25","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/mds.22137","volume":"23","author":"C Toth","year":"2008","unstructured":"Toth, C., Brown, M. S., Furtado, S., Suchowersky, O., & Zochodne, D. (2008). Neuropathy as a potential complication of levodopa use in Parkinson\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 23(13), 1850\u20131859.","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"354_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00702-020-02276-x","volume":"128","author":"S Greten","year":"2021","unstructured":"Greten, S., M\u00fcller-Funogea, J. I., Wegner, F., H\u00f6glinger, G. U., Simon, N., Junius-Walker, U., Gerbel, S., Krause, O., & Klietz, M. (2021). Drug safety profiles in geriatric patients with Parkinson\u2019s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis. Journal of Neural Transmission., 128(1), 49\u201360.","journal-title":"Journal of Neural Transmission."},{"issue":"6","key":"354_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40266-019-00654-z","volume":"36","author":"M Klietz","year":"2019","unstructured":"Klietz, M., Greten, S., Wegner, F., & H\u00f6glinger, G. U. (2019). Safety and tolerability of pharmacotherapies for Parkinson\u2019s disease in geriatric patients. Drugs & Aging, 36(6), 511\u2013530.","journal-title":"Drugs & Aging"},{"issue":"8","key":"354_CR28","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4103\/1673-5374.332122","volume":"17","author":"CM Labandeira","year":"2022","unstructured":"Labandeira, C. M., Fraga-Bau, A., Arias Ron, D., Alvarez-Rodriguez, E., Vicente-Alba, P., Lago-Garma, J., & Rodriguez-Perez, A. I. (2022). Parkinson\u2019s disease and diabetes mellitus: Common mechanisms and treatment repurposing. Neural Regeneration Research, 17(8), 1652\u20131658.","journal-title":"Neural Regeneration Research"},{"issue":"4","key":"354_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/jns.12099","volume":"19","author":"A Vital","year":"2014","unstructured":"Vital, A., Lepreux, S., & Vital, C. (2014). Peripheral neuropathy and parkinsonism: A large clinical and pathogenic spectrum. Journal of the Peripheral Nervous System: JPNS, 19(4), 333\u2013342.","journal-title":"Journal of the Peripheral Nervous System: JPNS"},{"issue":"3","key":"354_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1212\/01.wnl.0000171859.85078.3d","volume":"65","author":"Y Ohsawa","year":"2005","unstructured":"Ohsawa, Y., Kurokawa, K., Sonoo, M., Yamada, H., Hemmi, S., Iwatsuki, K., Hagiwara, H., Murakami, T., Shirabe, T., Shimizu, T., & Sunada, Y. (2005). Reduced amplitude of the sural nerve sensory action potential in PARK2 patients. Neurology, 65(3), 459\u2013462.","journal-title":"Neurology"},{"issue":"8","key":"354_CR31","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/mds.20113","volume":"19","author":"G Abbruzzese","year":"2004","unstructured":"Abbruzzese, G., Pigullo, S., Schenone, A., Bellone, E., Marchese, R., Di Maria, E., Benedetti, L., Ciotti, P., Nobbio, L., Bonifati, V., Ajmar, F., & Mandich, P. (2004). Does parkin play a role in the peripheral nervous system? A family report. Movement Disorders: Official Journal of the Movement Disorder Society, 19(8), 978\u2013981.","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"354_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/mdc3.12688","volume":"6","author":"A Romagnolo","year":"2019","unstructured":"Romagnolo, A., Merola, A., Artusi, C. A., Rizzone, M. G., Zibetti, M., & Lopiano, L. (2019). Levodopa-induced neuropathy: A systematic review. Movement Disorders Clinical Practice, 6(2), 96\u2013103.","journal-title":"Movement Disorders Clinical Practice"},{"key":"354_CR33","doi-asserted-by":"publisher","first-page":"1023574","DOI":"10.3389\/fnagi.2022.1023574","volume":"14","author":"J Dulski","year":"2022","unstructured":"Dulski, J., Uitti, R. J., Ross, O. A., & Wszolek, Z. K. (2022). Genetic architecture of Parkinson\u2019s disease subtypes \u2013 Review of the literature. Frontiers in Aging Neuroscience, 14, 1023574.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"354_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ana.22021","volume":"68","author":"C Toth","year":"2010","unstructured":"Toth, C., Breithaupt, K., Ge, S., Duan, Y., Terris, J. M., Thiessen, A., Wiebe, S., Zochodne, D. W., & Suchowersky, O. (2010). Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Annals of Neurology, 68(1), 28\u201336.","journal-title":"Annals of Neurology"},{"issue":"6","key":"354_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.4103\/aian.aian_669_22","volume":"25","author":"A Ramachandran","year":"2022","unstructured":"Ramachandran, A., Jose, J., Gafoor, V. A., Das, S., & Balaram, N. (2022). Prevalence and risk factors of peripheral neuropathy in Parkinson\u2019s disease. Annals of Indian Academy of Neurology, 25(6), 1109\u20131115.","journal-title":"Annals of Indian Academy of Neurology"},{"issue":"13","key":"354_CR36","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid, R., & Herrmann, W. (2006). Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Letters, 580(13), 2994\u20133005.","journal-title":"FEBS Letters"},{"key":"354_CR37","doi-asserted-by":"publisher","first-page":"9968228","DOI":"10.1155\/2021\/9968228","volume":"2021","author":"S Baltrusch","year":"2021","unstructured":"Baltrusch, S. (2021). The role of neurotropic B vitamins in nerve regeneration. BioMed Research International, 2021, 9968228.","journal-title":"BioMed Research International"},{"issue":"10","key":"354_CR38","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3390\/jcm8101533","volume":"8","author":"OM Vanta","year":"2019","unstructured":"Vanta, O. M., Tohanean, N., Pintea, S., & Perju-Dumbrava, L. (2019). Large-fiber neuropathy in Parkinson\u2019s disease: Clinical, biological, and electroneurographic assessment of a Romanian cohort. Journal of Clinical Medicine, 8(10), 1533.","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"354_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.parkreldis.2012.08.002","volume":"19","author":"N Shahrizaila","year":"2013","unstructured":"Shahrizaila, N., Mahamad, U. A., Yap, A.-C., Choo, Y.-M., Marras, C., & Lim, S.-Y. (2013). Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson\u2019s disease? Parkinsonism & Related Disorders, 19(3), 391\u2013393.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"354_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/archneur.61.5.657","volume":"61","author":"T M\u00fcller","year":"2004","unstructured":"M\u00fcller, T., Renger, K., & Kuhn, W. (2004). Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Archives of Neurology, 61(5), 657\u2013660.","journal-title":"Archives of Neurology"},{"issue":"12","key":"354_CR41","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3349\/ymj.2020.61.12.1050","volume":"61","author":"JJ Lee","year":"2020","unstructured":"Lee, J. J., & Baik, J. S. (2020). Peripheral Neuropathy in de novo Patients with Parkinson\u2019s disease. Yonsei Medical Journal, 61(12), 1050\u20131053.","journal-title":"Yonsei Medical Journal"},{"issue":"1","key":"354_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/aian.AIAN_478_18","volume":"23","author":"NL Mathukumalli","year":"2020","unstructured":"Mathukumalli, N. L., Kandadai, M. R., Shaik, J. A., Kanikannan, M. A., & Borgohain, R. (2020). Serum B12, homocysteine levels, and their effect on peripheral neuropathy in Parkinson\u2019s disease: Indian cohort. Annals of Indian Academy of Neurology, 23(1), 48\u201353.","journal-title":"Annals of Indian Academy of Neurology"},{"issue":"3","key":"354_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ene.12846","volume":"23","author":"A Merola","year":"2016","unstructured":"Merola, A., Romagnolo, A., Zibetti, M., Bernardini, A., Cocito, D., & Lopiano, L. (2016). Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment. European Journal of Neurology, 23(3), 501\u2013509.","journal-title":"European Journal of Neurology"},{"issue":"1","key":"354_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","volume":"20","author":"F Mancini","year":"2014","unstructured":"Mancini, F., Comi, C., Oggioni, G. D., Pacchetti, C., Calandrella, D., Coletti Moja, M., Riboldazzi, G., Tunesi, S., Dal Fante, M., Manfredi, L., Lacerenza, M., Cantello, R., & Antonini, A. (2014). Prevalence and features of peripheral neuropathy in Parkinson\u2019s disease patients under different therapeutic regimens. Parkinsonism & Related Disorders, 20(1), 27\u201331.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"354_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/brb3.698","volume":"7","author":"S Loens","year":"2017","unstructured":"Loens, S., Chorbadzhieva, E., Kleimann, A., Dressler, D., & Schrader, C. (2017). Effects of levodopa\/carbidopa intestinal gel versus oral levodopa\/carbidopa on B vitamin levels and neuropathy. Brain and Behavior, 7(5), 698.","journal-title":"Brain and Behavior"},{"issue":"6","key":"354_CR46","doi-asserted-by":"publisher","first-page":"e66639","DOI":"10.1371\/journal.pone.0066639","volume":"8","author":"C Jugel","year":"2013","unstructured":"Jugel, C., Ehlen, F., Taskin, B., Marzinzik, F., M\u00fcller, T., & Klostermann, F. (2013). Neuropathy in Parkinson\u2019s disease patients with intestinal levodopa infusion versus oral drugs. PLoS ONE, 8(6), e66639.","journal-title":"PLoS ONE"},{"issue":"3","key":"354_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00702-011-0689-3","volume":"119","author":"F Klostermann","year":"2012","unstructured":"Klostermann, F., Jugel, C., M\u00fcller, T., & Marzinzik, F. (2012). Malnutritional neuropathy under intestinal levodopa infusion. Journal of Neural Transmission, 119(3), 369\u2013372.","journal-title":"Journal of Neural Transmission"},{"issue":"12","key":"354_CR48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","volume":"21","author":"MJ Soileau","year":"2022","unstructured":"Soileau, M. J., Aldred, J., Budur, K., Fisseha, N., Fung, V. S., Jeong, A., Kimber, T. E., Klos, K., Litvan, I., O\u2019Neill, D., Robieson, W. Z., Spindler, M. A., Standaert, D. G., Talapala, S., Vaou, E. O., Zheng, H., Facheris, M. F., & Hauser, R. A. (2022). Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson\u2019s disease: A randomised, double-blind, active-controlled, phase 3 trial. The Lancet. Neurology, 21(12), 1099\u20131109.","journal-title":"The Lancet. Neurology"},{"key":"354_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12883-016-0667-3","volume":"16","author":"DF de Ara\u00fajo","year":"2016","unstructured":"de Ara\u00fajo, D. F., de Melo Neto, A. P., Oliveira, \u00cd. S. C., Brito, B. S., de Ara\u00fajo, I. T., Barros, I. S., Lima, J. W. O., Horta, W. G., & Gondim, Fd. A. A. (2016). Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism. BMC Neurology, 16, 3. https:\/\/doi.org\/10.1186\/s12883-016-0667-3","journal-title":"BMC Neurology"},{"key":"354_CR50","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1007\/s00415-024-12579-8","volume":"271","author":"EH Kwon","year":"2024","unstructured":"Kwon, E. H., Bieber, A., Sch\u00fclken, P., M\u00fcller, K., K\u00fchn, E., Averdunk, P., Kools, S., Hilker, L., Kirchg\u00e4ssler, A., Ebner, L., Ortmann, L., Basner, L., Steininger, J., Kleinz, T., Motte, J., Fisse, A. L., Schneider-Gold, C., Gold, R., Scherbaum, R., \u2026 Pitarokoili, K. (2024). Longitudinal evaluation of polyneuropathy in Parkinson\u2019s disease. Journal of Neurology., 271, 6136.","journal-title":"Journal of Neurology."},{"issue":"2","key":"354_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","volume":"64","author":"JD England","year":"2005","unstructured":"England, J. D., Gronseth, G. S., Franklin, G., Miller, R. G., Asbury, A. K., Carter, G. T., Cohen, J. A., Fisher, M. A., Howard, J. F., Kinsella, L. J., Latov, N., Lewis, R. A., Low, P. A., & Sumner, A. J. (2005). Distal symmetric polyneuropathy: A definition for clinical research: Report of the American academy of neurology, the American association of electrodiagnostic medicine, and the American academy of physical medicine and rehabilitation. Neurology, 64(2), 199\u2013207.","journal-title":"Neurology"},{"key":"354_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010974.pub2","author":"R Zhirong Yang","year":"2018","unstructured":"Zhirong Yang, R., Chen, Y. Z., Huang, Y., Hong, T., Sun, F., Ji, L., & Zhan, S. (2018). Scoring systems to screen for diabetic peripheral neuropathy. Cochrane Database of Systematic Reviews. https:\/\/doi.org\/10.1002\/14651858.CD010974.pub2","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"354_CR53","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ana.410080608","volume":"8","author":"PJ Dyck","year":"1980","unstructured":"Dyck, P. J., Sherman, W. R., Hallcher, L. M., Service, F. J., O\u2019BrienGrina, P. C. L. A., Palumbo, P. J., & Swanson, C. J. (1980). Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Annals of Neurology, 8(6), 590\u2013596.","journal-title":"Annals of Neurology"},{"issue":"2","key":"354_CR54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00400697","volume":"36","author":"MJ Young","year":"1993","unstructured":"Young, M. J., Boulton, A. J., MacLeod, A. F., Williams, D. R., & Sonksen, P. H. (1993). A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 36(2), 150\u2013154.","journal-title":"Diabetologia"},{"issue":"4","key":"354_CR55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/mus.1040","volume":"24","author":"I Feki","year":"2001","unstructured":"Feki, I., & Lefaucheur, J. P. (2001). Correlation between nerve conduction studies and clinical scores in diabetic neuropathy. Muscle & nerve, 24(4), 555\u2013558.","journal-title":"Muscle & nerve"},{"issue":"11","key":"354_CR56","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","volume":"25","author":"V Bril","year":"2002","unstructured":"Bril, V., & Perkins, B. A. (2002). Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care, 25(11), 2048\u20132052.","journal-title":"Diabetes Care"},{"issue":"1","key":"354_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nic.2013.03.023","volume":"24","author":"T Chung","year":"2013","unstructured":"Chung, T., Prasad, K., & Lloyd, T. E. (2013). Peripheral neuropathy \u2013 clinical and electrophysiological considerations. Neuroimaging Clinics of North America, 24(1), 49\u201365.","journal-title":"Neuroimaging Clinics of North America"},{"issue":"8","key":"354_CR58","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/mds.27025","volume":"32","author":"A Merola","year":"2017","unstructured":"Merola, A., Rosso, M., Romagnolo, A., Comi, C., Fasano, A., Zibetti, M., Lopez-Castellanos, J. R., Cocito, D., Lopiano, L., & Espay, A. J. (2017). Peripheral neuropathy as marker of severe Parkinson\u2019s disease phenotype. Movement Disorders: Official Journal of the Movement Disorder Society, 32(8), 1256\u20131258.","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"5","key":"354_CR59","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mus.26029","volume":"57","author":"JA Telleman","year":"2018","unstructured":"Telleman, J. A., Grimm, A., Goedee, S., Visser, L. H., & Zaidman, C. M. (2018). Nerve ultrasound in polyneuropathies. Muscle & Nerve, 57(5), 716\u2013728.","journal-title":"Muscle & Nerve"},{"issue":"11","key":"354_CR60","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK van den Bergh","year":"2021","unstructured":"van den Bergh, P. Y. K., van Doorn, P. A., Hadden, R. D. M., Avau, B., Vankrunkelsven, P., Allen, J. A., Attarian, S., Blomkwist-Markens, P. H., Cornblath, D. R., Eftimov, F., Goedee, H. S., Harbo, T., Kuwabara, S., Lewis, R. A., Lunn, M. P., Nobile-Orazio, E., Querol, L., Rajabally, Y. A., Sommer, C., & Topaloglu, H. A. (2021). European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force-second revision. European Journal of Neurology, 28(11), 3556\u20133583.","journal-title":"European Journal of Neurology"},{"issue":"3","key":"354_CR61","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1529-8027.2010.00276.x","volume":"15","author":"CL Sommer","year":"2010","unstructured":"Sommer, C. L., Brandner, S., Dyck, P. J., Harati, Y., LaCroix, C., Lammens, M., Magy, L., Mellgren, S. I., Morbin, M., Navarro, C., Powell, H. C., Schenone, A. E., Tan, E., Urtizberea, A., & Weis, J. (2010). Peripheral nerve society guideline on processing and evaluation of nerve biopsies. Journal of the Peripheral Nervous System: JPNS, 15(3), 164\u2013175.","journal-title":"Journal of the Peripheral Nervous System: JPNS"},{"issue":"2","key":"354_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanp\u00e4\u00e4, M., Hansson, P., Jensen, T. S., Kamerman, P. R., Lund, K., Moore, A., Raja, S. N., Rice, A. S. C., Rowbotham, M., Sena, E., Siddall, P., Smith, B. H., & Wallace, M. (2015). Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. The Lancet. Neurology, 14(2), 162\u2013173.","journal-title":"The Lancet. Neurology"},{"issue":"1","key":"354_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0002-9343(96)00381-6","volume":"102","author":"WL Olson","year":"1997","unstructured":"Olson, W. L., Gruenthal, M., Mueller, M. E., & Olson, W. H. (1997). Gabapentin for parkinsonism: A double-blind, placebo-controlled, crossover trial. The American Journal of Medicine, 102(1), 60\u201366.","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"354_CR64","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00002826-200405000-00007","volume":"27","author":"N van Blercom","year":"2004","unstructured":"van Blercom, N., Lasa, A., Verger, K., Masram\u00f3n, X., Sastre, V. M., & Linazasoro, G. (2004). Effects of gabapentin on the motor response to levodopa: A double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease. Clinical Neuropharmacology, 27(3), 124\u2013128.","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"354_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/wnf.0b013e3180340319","volume":"30","author":"R Djaldetti","year":"2007","unstructured":"Djaldetti, R., Yust-Katz, S., Kolianov, V., Melamed, E., & Dabby, R. (2007). The effect of duloxetine on primary pain symptoms in Parkinson disease. Clinical Neuropharmacology, 30(4), 201\u2013205.","journal-title":"Clinical Neuropharmacology"},{"issue":"12","key":"354_CR66","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","volume":"14","author":"C Trenkwalder","year":"2015","unstructured":"Trenkwalder, C., Chaudhuri, K. R., Martinez-Martin, P., Rascol, O., Ehret, R., Vali\u0161, M., S\u00e1tori, M., Krygowska-Wajs, A., Marti, M. J., Reimer, K., Oksche, A., Lomax, M., DeCesare, J., & Hopp, M. (2015). Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA): A double-blind, randomised, placebo-controlled trial. The Lancet. Neurology, 14(12), 1161\u20131170.","journal-title":"The Lancet. Neurology"},{"issue":"5","key":"354_CR67","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40279-021-01596-6","volume":"52","author":"F Streckmann","year":"2022","unstructured":"Streckmann, F., Balke, M., Cavaletti, G., Toscanelli, A., Bloch, W., D\u00e9card, B. F., Lehmann, H. C., & Faude, O. (2022). Exercise and neuropathy: Systematic review with meta-analysis. Sports Medicine, 52(5), 1043\u20131065.","journal-title":"Sports Medicine"},{"issue":"6","key":"354_CR68","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1545968315613447","volume":"30","author":"X Shen","year":"2016","unstructured":"Shen, X., Wong-Yu, I. S. K., & Mak, M. K. Y. (2016). Effects of exercise on falls, balance, and gait ability in Parkinson\u2019s disease: A meta-analysis. Neurorehabilitation and neural repair, 30(6), 512\u2013527.","journal-title":"Neurorehabilitation and neural repair"},{"issue":"11","key":"354_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.heliyon.2021.e08281","volume":"7","author":"G Maugeri","year":"2021","unstructured":"Maugeri, G., D\u2019Agata, V., Trovato, B., Roggio, F., Castorina, A., Vecchio, M., Di Rosa, M., & Musumeci, G. (2021). The role of exercise on peripheral nerve regeneration: from animal model to clinical application. Heliyon, 7(11), 1.","journal-title":"Heliyon"},{"issue":"6","key":"354_CR70","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ane.12783","volume":"136","author":"V Rispoli","year":"2017","unstructured":"Rispoli, V., Simioni, V., Capone, J. G., Golfr\u00e8 Andreasi, N., Preda, F., Sette, E., Tugnoli, V., & Sensi, M. (2017). Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation. Acta neurologica Scandinavica, 136(6), 660\u2013667.","journal-title":"Acta neurologica Scandinavica"},{"issue":"5","key":"354_CR71","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/jnnp-2014-308586","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini, A., Eleopra, R., & Onofrj, M. (2015). Polyneuropathy associated with duodenal infusion of levodopa in Parkinson\u2019s disease: Features, pathogenesis and management. Journal of neurology, neurosurgery, and psychiatry, 86(5), 490\u2013495.","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"1","key":"354_CR72","first-page":"19","volume":"49","author":"J Taher","year":"2022","unstructured":"Taher, J., Naranian, T., Poon, Y.-Y., Merola, A., Mestre, T., Suchowersky, O., Kulasingam, V., & Fasano, A. (2022). Vitamins and infusion of levodopa-carbidopa intestinal gel. Le Journal Canadien Des Sciences Neurologiques, 49(1), 19\u201328.","journal-title":"Le Journal Canadien Des Sciences Neurologiques"},{"key":"354_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.04.016","volume":"27","author":"G Cossu","year":"2016","unstructured":"Cossu, G., Ceravolo, R., Zibetti, M., Arca, R., Ricchi, V., Paribello, A., Murgia, D., Merola, A., Romagnolo, A., Nicoletti, V., Palermo, G., Mereu, A., Lopiano, L., Melis, M., Abbruzzese, G., & Bonuccelli, U. (2016). Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition. Parkinsonism & related disorders, 27, 81\u201384.","journal-title":"Parkinsonism & related disorders"},{"issue":"9","key":"354_CR74","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/cells11091511","volume":"11","author":"T M\u00fcller","year":"2022","unstructured":"M\u00fcller, T., Schlegel, E., Zingler, S., & Thiede, H. M. (2022). Effects of one-day application of levodopa\/carbidopa\/Entacapone versus levodopa\/carbidopa\/Opicapone in Parkinson\u2019s disease patients. Cells, 11(9), 1511.","journal-title":"Cells"},{"issue":"2","key":"354_CR75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/mdc3.13926","volume":"11","author":"V Viljaharju","year":"2024","unstructured":"Viljaharju, V., Mertsalmi, T., Pauls, K. A. M., Koivu, M., Eerola-Rautio, J., Udd, M., & Pekkonen, E. (2024). Levodopa-Entacapone-carbidopa intestinal gel treatment in advanced Parkinson\u2019s disease: A single-center study of 30 patients. Movement Disorders Clinical Practice, 11(2), 159\u2013165.","journal-title":"Movement Disorders Clinical Practice"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-024-00354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-024-00354-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-024-00354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:43:41Z","timestamp":1730105021000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-024-00354-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/s42466-024-00354-z","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}